Fast Track Initiative
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
RegCell | Sep 2026Participated | $66 MSeries A | |
Neusignal Therapeutics | Jul 2026Participated | $33 MSeries B | |
Storm Therapeutics | Apr 2026Participated | $56 MSeries C | |
Sonire Therapeutics | Apr 2026Participated | $18 MSeries A | |
Quali | Feb 2026Led | $11 MSeries A | |
Metagen Therapeutics | Sep 2025Participated | $16 MSeries B | |
RegCell | Mar 2025Led | $9 MSeed | |
A10 Lab | Jan 2024Participated | $3 MSeries A | |
Shinobi Therapeutics | Dec 2023Participated | $51 MSeries A | |
CellFiber | Nov 2023Participated | $6 MOther Equity | |
AIRNA | Sep 2023Participated | $30 MOther Equity | |
Metagen Therapeutics | Jun 2023Participated | $12 MSeries A | |
RegCell | Sep 2026Participated | $66 MSeries A | |
Neusignal Therapeutics | Jul 2026Participated | $33 MSeries B | |
Storm Therapeutics | Apr 2026Participated | $56 MSeries C | |
Sonire Therapeutics | Apr 2026Participated | $18 MSeries A | |
Quali | Feb 2026Led | $11 MSeries A | |
Metagen Therapeutics | Sep 2025Participated | $16 MSeries B | |
RegCell | Mar 2025Led | $9 MSeed | |
A10 Lab | Jan 2024Participated | $3 MSeries A | |
Shinobi Therapeutics | Dec 2023Participated | $51 MSeries A | |
CellFiber | Nov 2023Participated | $6 MOther Equity | |
AIRNA | Sep 2023Participated | $30 MOther Equity | |
Metagen Therapeutics | Jun 2023Participated | $12 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 0 |
| Series A | 2 | 7 |
| Series B | 1 | 4 |
| Series C+ | 0 | 2 |
| Other Equity | 1 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Aug '18 | 1 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 1 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 1 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 2 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 1 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 1 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 0 |
| Nov '23 | 1 |
| Dec '23 | 1 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 2 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 1 |
| Aug '26 | 0 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 19 |
| AI & Machine Learning | 2 |
| Space & Frontier Tech | 2 |
| Networks, Cloud & Communication | 1 |
| Hardware & Robotics | 1 |
| Enterprise Software | 1 |
| Media & Entertainment | 1 |
| Professional Services | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 2 |
| $5M-$10M | 4 |
| $10M-$25M | 5 |
| $25M-$50M | 5 |
| $50M-$100M | 4 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Japan | 13 |
| United States | 5 |
| Europe | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Jafco Ventures | 5 |
| Keio Innovation Initiative | 5 |
| Nippon Venture Capital | 5 |
| SMBC Venture Capital | 5 |
| UTokyo Innovation Platform | 4 |
| Mizuho Capital | 3 |
| Daiwa Corporate Investment | 2 |
| IP Group | 2 |
| JIC Venture Growth Investments | 2 |
| Kyoto University Innovation Capital | 2 |
| M Ventures | 2 |
| Mitsubishi UFJ Capital | 2 |
| Nissay Capital | 2 |
| Osaka University Venture Capital | 2 |
| Pfizer Ventures | 2 |
| Remiges Ventures | 2 |
| SBI Investment | 2 |
| SPARX Asset Management | 2 |
| Taiho Ventures | 2 |
| University of Tokyo Edge Capital | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 25% |
| Participating | 15 | 75% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 40% |
| Co-led | 3 | 60% |
Team
Principal
Analyst
Business Management
Associate
Executive Vice President
Associate
Vice President
Principal
COO & Managing Partner